Literature DB >> 11992391

Local excision and postoperative radiation therapy for rectal adenocarcinoma.

W M Mendenhall1, C G Morris, W R Rout, R A Zlotecki, D S Lind, S N Hochwald, S R Schell, E M Copeland.   

Abstract

Sixty-seven patients with early-stage adenocarcinoma of the rectum who had lesions thought to be unsuitable for either local excision alone or endocavitary irradiation were treated with local excision followed by postoperative radiation therapy. The purpose of this study was to evaluate the effectiveness of local excision followed by radiation therapy for treatment of rectal adenocarcinoma. The patients were treated between 1974 and 1999; follow-up time was 6 to 273 months (median, 65 months). All living patients had follow-up for at least 2 years. The indications for postoperative irradiation included equivocal or positive margins, invasion of the muscularis propria, endothelial-lined space invasion, poorly differentiated histology, and perineural invasion. Cox proportional hazards regression analysis was performed using six explanatory variables including tumor size, configuration (exophytic vs. ulcerative), histologic differentiation, pathologic T stage, endothelial-lined space invasion, and margin status. The time interval between treatment and development of recurrent disease was in the range of 11 to 48 months. The 5-year results were as follows: local-regional control, 86%; ultimate local-regional control, 93%; distant metastasis-free survival, 93%; absolute survival, 80%; and cause-specific survival, 90%. When the Cox proportional hazards regression analysis was performed for these endpoints, margin status influenced absolute survival (P = 0.0074), cause-specific survival (P = 0.0405), and ultimate local-regional control (P = 0.0439). Tumor configuration marginally influenced cause-specific survival (P = 0.0577). None of the variables had an influence on the endpoints' local-regional control, ultimate local-regional control with sphincter preservation, or distant metastasis. Five patients (7%) had severe complications; no complication was fatal. Local excision and postoperative radiation therapy results in a high probability of local-regional control and survival for selected patients with relatively early-stage rectal adenocarcinoma. Patients with ulcerative tumors may have a lower likelihood of cause-specific survival. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11992391     DOI: 10.1002/ijc.10354

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Depth of tumor invasion independently predicts lymph node metastasis in T2 rectal cancer.

Authors:  Pei-Rong Ding; Xin An; Yun Cao; Xiao-Jun Wu; Li-Ren Li; Gong Chen; Zhen-Hai Lu; Yu-Jing Fang; De-Sen Wan; Zhi-Zhong Pan
Journal:  J Gastrointest Surg       Date:  2010-10-05       Impact factor: 3.452

2.  Transanal excision with radiation therapy for rectal adenocarcinoma.

Authors:  Nathan Tennyson; William M Mendenhall; Christopher G Morris; Emina H Huang; Robert A Zlotecki
Journal:  Clin Med Res       Date:  2012-09-20

3.  Effectiveness of adjuvant radiotherapy after local excision of rectal cancer with deep submucosal invasion: a single-hospital, case-control analysis.

Authors:  Seohyun Lee; Chang Gok Woo; Hyo Jeong Lee; Kyung-Jo Kim; Byong Duk Ye; Jeong-Sik Byeon; Seung-Jae Myung; Suk-Kyun Yang; Young Soo Park; Jin-Hong Park; Jong Hoon Kim; Seok-Byung Lim; Jin Cheon Kim; Chang Sik Yu; Dong-Hoon Yang
Journal:  Surg Endosc       Date:  2015-02-12       Impact factor: 4.584

4.  Long-term oncologic results of patients with distal rectal cancer treated by local excision with or without adjuvant treatment.

Authors:  Byung Soh Min; Nam Kyu Kim; Yong Taek Ko; Kang Young Lee; Seung Hyuk Baek; Chang Hwan Cho; Seung Kook Sohn
Journal:  Int J Colorectal Dis       Date:  2007-06-12       Impact factor: 2.571

Review 5.  Radiation therapy for rectal cancer.

Authors:  Michelle Tseng; Yu Yang Soon; Balamurugan Vellayappan; Francis Ho; Jeremy Tey
Journal:  J Gastrointest Oncol       Date:  2019-12

6.  A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancer.

Authors:  W A A Borstlap; P J Tanis; T W A Koedam; C A M Marijnen; C Cunningham; E Dekker; M E van Leerdam; G Meijer; N van Grieken; I D Nagtegaal; C J A Punt; M G W Dijkgraaf; J H De Wilt; G Beets; E J de Graaf; A A W van Geloven; M F Gerhards; H L van Westreenen; A W H van de Ven; P van Duijvendijk; I H J T de Hingh; J W A Leijtens; C Sietses; E J Spillenaar-Bilgen; R J C L M Vuylsteke; C Hoff; J W A Burger; W M U van Grevenstein; A Pronk; R J I Bosker; H Prins; A B Smits; S Bruin; D D Zimmerman; L P S Stassen; M S Dunker; M Westerterp; P P Coene; J Stoot; W A Bemelman; J B Tuynman
Journal:  BMC Cancer       Date:  2016-07-21       Impact factor: 4.430

7.  Transanal endoscopic microsurgery for rectal lesions in a specialist regional early rectal cancer centre: the Mersey experience.

Authors:  M Ondhia; P Tamvakeras; P O'Toole; A Montazerri; T Andrews; C Farrell; S Ahmed; S Slawik; S Ahmed
Journal:  Colorectal Dis       Date:  2019-07-01       Impact factor: 3.788

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.